Deal includes shares of common stock, class E warrants and D warrants
By Susanna Moon
Chicago, March 9 – Cardax, Inc. raised $290,000 in the non-brokered private placement of 966,665 units of shares and warrants, according to an 8-K filing with the Securities and Exchange Commission.
The company entered into separate subscription agreements, registration rights agreements and warrant purchase agreements.
The company said it issued shares of common stock and class E warrants and D warrants.
The units consisted of: (a) shares of common stock at a price per share of $0.30, (b) two class D warrants, each to purchase one share at a price per share of $0.10, and (c) one class E warrant to purchase three-quarters of one share at a price per share of $0.1667. The class D warrants and the class E warrants will expire March 31, 2020.
Cardax, formerly Cardax Pharma, Inc., is a private life sciences company based in Washington Boro, Pa.
| Issuer: | Cardax, Inc.
|
| Issue: | Common stock and class E warrants and D warrants
|
| Amount: | $290,000
|
| Units: | 966,665
|
| Price: | $0.30
|
| Warrants: | Two class D warrants, one 0.75 of a share class E warrant
|
| Warrant expiration: | March 31, 2020
|
| Warrant strike price: | $0.10 for class D warrants; $0.1667 for class E warrants
|
| Pricing date: | March 9
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
